Alpha-particles for targeted therapy
- 15 September 2008
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 60 (12), 1402-1406
- https://doi.org/10.1016/j.addr.2008.04.007
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Antibody therapy for residual disease in acute myelogenous leukemiaCritical Reviews in Oncology/Hematology, 2001
- Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle RadiotherapyCurrent Pharmaceutical Design, 2000
- Tumor control probability model for alpha-particle-emitting radionuclides.Radiation Research, 2000
- Values of “S,” and for dosimetry using alpha‐particle emittersMedical Physics, 1999
- Radioimmunotherapy with alpha-emitting nuclidesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Alpha-Emitters for Medical Therapy: Workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996Radiation Research, 1997
- Microdosimetric concepts in radioimmunotherapyMedical Physics, 1993
- The feasibility of 225 Ac as a source of ??-particles in radioimmunotherapyNuclear Medicine Communications, 1993
- Impairment of the Proliferative Capacity of Human Cells in Culture by α-particles with Differing Linear-energy TransferInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1964
- Dose-Survival Curves of Human Cells in Tissue Culture Irradiated with Alpha-, Beta-, 20-KV. X- and 200-KV. X-RadiationNature, 1962